Oral pharmacological chaperone protein therapies to address diseases that result from protein misfolding
- Year invested 2004
- Investment Stage Public/PIPES
- Sectors
- Investment Status Current
- Website amicustherapeutics.com
- Company Status IPO/Public (Nasdaq: FOLD)